Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate
Home
Publications
Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate
Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate
Author:
WB
W Berry
W Berry
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Publisher website
Google Scholar
31 August 2001
journal article
Published by
Elsevier
in
Seminars in Oncology
Vol. 28
,
8-15
DOI:
10.1016/s0093-7754(01)90149-6
PMID:
11685723
Abstract
No abstract available
Keywords
SURVIVAL
EFFICACY
PROSTATE
HORMONE REFRACTORY
SINGLE AGENT DOCETAXEL
WEEKLY
ANTIGEN
TREATMENT
Cited
Cited by 134 articles
Scroll to top